Simcoe Capital Management LLC grew its position in shares of Ingevity Corporation (NYSE:NGVT – Free Report) by 49.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 933,455 shares of the company’s stock after purchasing an additional 308,520 shares during the quarter. Ingevity accounts for 7.5% of Simcoe Capital Management LLC’s holdings, making the stock its 7th largest holding. Simcoe Capital Management LLC’s holdings in Ingevity were worth $51,517,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of the company. Alpha Wave Global LP purchased a new position in shares of Ingevity during the third quarter valued at approximately $8,395,000. Glenmede Investment Management LP grew its stake in Ingevity by 10.3% in the 3rd quarter. Glenmede Investment Management LP now owns 8,291 shares of the company’s stock worth $458,000 after acquiring an additional 773 shares during the period. Boston Partners acquired a new position in Ingevity in the 3rd quarter valued at $14,171,000. Marshall Wace LLP raised its holdings in Ingevity by 217.4% in the 3rd quarter. Marshall Wace LLP now owns 228,201 shares of the company’s stock valued at $12,594,000 after acquiring an additional 156,301 shares during the last quarter. Finally, Entropy Technologies LP purchased a new position in shares of Ingevity during the 3rd quarter worth $361,000. Institutional investors and hedge funds own 91.59% of the company’s stock.
Analysts Set New Price Targets
NGVT has been the topic of several analyst reports. BMO Capital Markets restated an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a report on Monday, March 2nd. Zacks Research upgraded Ingevity to a “hold” rating in a research note on Tuesday, December 16th. Jefferies Financial Group reiterated a “buy” rating and set a $82.00 target price on shares of Ingevity in a research report on Thursday, February 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research note on Thursday, January 22nd. Finally, Wells Fargo & Company upped their price objective on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Ingevity has an average rating of “Hold” and an average target price of $80.00.
Ingevity Stock Up 0.9%
Shares of NGVT opened at $64.62 on Friday. Ingevity Corporation has a fifty-two week low of $28.49 and a fifty-two week high of $77.46. The company’s fifty day moving average is $68.67 and its two-hundred day moving average is $59.93. The firm has a market cap of $2.28 billion, a PE ratio of -13.90 and a beta of 1.31. The company has a quick ratio of 0.79, a current ratio of 1.33 and a debt-to-equity ratio of 39.10.
Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.16). The firm had revenue of $255.10 million for the quarter, compared to analyst estimates of $257.27 million. Ingevity had a positive return on equity of 126.25% and a negative net margin of 13.51%.The company’s quarterly revenue was down 3.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.95 earnings per share. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. Analysts forecast that Ingevity Corporation will post 4.45 earnings per share for the current year.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
See Also
- Five stocks we like better than Ingevity
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- $30 stock to buy before Starlink goes public (WATCH NOW!)
- This coin has everything going for it
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
